# Maxcyte, Inc.: Form 8-K, filed Nov 2, 2021

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2021-11-02
- Accepted by EDGAR: Nov 2, 2021, 16:30 ET
- Period: 2021-10-29
- Accession: 0001104659-21-133041
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000110465921133041/tm2131585d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000110465921133041/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000110465921133041/tm2131585d1_8k.htm

Filed Nov 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-133041. Last ingested by Listed: Nov 11, 2026, 01:53 ET. No prices; not investment advice.